Plain-English translation of NCT07356570 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to better understand long-COVID by studying patients who have ongoing symptoms months after their initial infection. This study will collect your medical history, symptoms, and biological samples (like blood) during one visit. The goal is to identify patterns in how long-COVID affects different people and discover what treatments might work best.
Many people continue to struggle with long-COVID symptoms long after their initial infection, but doctors don't yet fully understand why some people are more severely affected than others or which treatments work best. This research aims to solve that puzzle by identifying what makes certain patients' long-COVID cases more serious or complex.
You likely qualify if…
You likely don't qualify if…
You would attend one visit at either Hôpital Henry Gabrielle or Hôpital Lyon Sud, where researchers will collect your medical information and biological samples (such as blood). During this single visit, they will ask about your symptoms, medical history, and take samples to study. The study is designed to be straightforward—just one appointment where they gather the information they need to understand your long-COVID profile better.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
France
Sponsor
Hospices Civils de Lyon
Enrollment target
~150 participants
Started
June 2025
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sébastien Couraud, Pr
Hospices Civils de Lyon
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.